- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2006
- Public Summary Document (PSD) November 2006 PBAC Meeting - PDF
Erlotinib hydrochloride – November 2006
Erlotinib hydrochloride, film-coated tablets, 25 mg, 100 mg and 150 mg (base), Tarceva November 2006
Last updated
2 March 2007